Device That Displays Medical Information Regarding Any Tissue

Important thing to note is, this device is one of the foremost handheld devices necessary to accomplish true DNA sequencing for multiple data points, as opposed to inference-based techniques towards single data points or single nucleotide polymorphisms (SNPs). QMDx will concentrate on examining its device for tuberculosis (TB), sexually transmitted diseases (STDs) and cardiovascular disease. QMDx’s chief scientific officer, Jonathan O’Halloran said to #-Link-Snipped-#, "The reason why I invented this technology is to perform infectious-disease resistance sequencing in the field, at the patient’s side. It’s a problem that’s not received enough press in my opinion." O’Halloran passed two years in the Khayelitsha township near Cape Town in South Africa, where he was inspired to formulate the technology, ahead of  going on to co-found the company. "Many, many times we had patients test positive for TB and so the samples go on for resistance testing and two weeks later they come back as multi-drug-resistant XDR [extremely drug-resistant]-TB. The problem is we’ve prescribed a first-line therapeutic and the patient has gone back into the community, passed on XDR-TB and subsequently died. So we’ve wasted money and not contained the XDR. It’s a problem that is being repeated all over the world."

The company presently features a device, Q-POC, at starting phase of prototype testing, and wishes to hone it even more in the coming 18 months before attempting full trials. O’Halloran stated that his team maintained costs down either by using out-of-patent technology or developing new technology within the industry wherever royalty costs were to be avoided.